Selskabets formål er at udvikle og omsætte produkter til human helse samt udøve anden hermed forbunden virksomhed.
| Year | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2025 | 3.1 mio. | 1.6 mio. | 29 mio. | 3.7 mio. | 1 | |
CVR: 35820620
Secondary names: PHYTORECEPT ApS, NORDIC DRONABINOL ApS, CEmed ApS
UTAM Invest ApS registered with 100% ownership
Compared to 130 companies in Fremstilling af farmaceutiske præparater
Comparison is based on industry median values
Companies in the same industry and area
companydata.dk